Ferrosan Medical Devices is a global leader in topical adjunctive hemostatic devices, specializing in the development and manufacturing of products that assist clinical professionals in controlling bleeding during surgeries since 1947. In addition to its hemostatic product line, the company has expanded into the electromechanical medical device sector. Headquartered near Copenhagen, Ferrosan Medical Devices employs around 400 people and holds trademarks in over 100 countries.
Ferrosan Medical Devices projects steady global growth in the market for topical hemostatic devices through 2030, with the Asia-Pacific region identified as a particularly strong market with the highest growth potential. This region is expected to play a key role in driving future demand and expansion opportunities for the company.